Inhibition of advanced glycation end product formation by burdock root extract.
10.4163/jnh.2016.49.4.233
- Author:
Darye LEE
1
;
Choon Young KIM
Author Information
1. Department of Food and Nutrition, Yeungnam University, Gyeongbuk 38541, Korea. cykim@yu.ac.kr
- Publication Type:Original Article
- Keywords:
burdock root extract;
glycation of bovine serum albumin;
hyperglycemia;
diabetes complications
- MeSH:
Arctium*;
Blood Glucose;
Diabetes Complications;
Fructosamine;
Fructose;
Galactose;
Glucose;
Glycosylation End Products, Advanced;
Hyperglycemia;
Serum Albumin, Bovine
- From:Journal of Nutrition and Health
2016;49(4):233-240
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: Diabetic complications are a major concern to manage progression of diabetes. Production of advanced glycation end products (AGEs) due to high blood glucose is one of the mechanisms leading to diabetic complications. Multiple pharmacologic AGE inhibitory agents are currently under development, but clinical applications are still limited due to safety issues. Thus, it is necessary to identify a safe anti-glycation agent. It is known that burdock roots have antioxidant, anti-inflammatory, and anti-cancer activities. The objective of the present study was to investigate the inhibitory role of burdock roots on the formation of high glucose-induced glycation of bovine serum albumin (BSA). METHODS: In this study, glycation of BSA by glucose, galactose, or fructose at 37℃ for 3 weeks was assessed based on levels of α-dicarbonyl compounds (early-stage glycation products), fructosamine (intermediate products of glycation), and fluorescent AGEs (late-stage glycation products). In order to compare the inhibitory actions of burdock root extract in AGE formation, aminoguanidine (AG), a pharmacological AGE inhibitor, was used as a positive control. RESULTS: BSA glycation by glucose, fructose, and galatose was dose- and time-dependently produced. Burdock root extract at a concentration of 4 mg/mL almost completely inhibited glucose-induced BSA glycation. The results demonstrate that burdock root extract inhibited AGE formation with an IC₅₀ value of 1.534 mg/mL, and inhibitory activity was found to be more effective than the standard anti-glycation agent aminoguanidine. This study identified a novel function of burdock root as a potential anti-glycation agent. CONCLUSION: Our findings suggest that burdock root could be beneficial for preventing diabetic complications.
